Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes. Xu Y, Malek ND, Chang AR, Echouffo-Tcheugui JB, et al. Nat Med 2026;32:1682-1685.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Y, Malek ND, Chang AR, Echouffo-Tcheugui JB, et al. Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes. Nat Med 2026;32:1682-1685.
PMID: 41857198